TOP STORIES

• REGULATORY Drug Prices Cut by 4.67% in FY2024 Revision, 314 APIs to Keep Full Prices with PMP
  March 5, 2024

• REGULATORY MHLW to Ask All Generic Makers in Japan to Execute Self-Inspections
  March 4, 2024

• BUSINESS Moderna Japan Taps Kazumasa Nagayama as New President
  March 4, 2024

• REGULATORY Generic Mergers, Product Consolidations Unlikely to Pose Antitrust Issue: FTC Official
  March 1, 2024

• REGULATORY MHLW Sets Out to Beef Up Inspector Skills with Nationwide Sharing of GMP Reports
  February 29, 2024

• BUSINESS Insmed Revs Up for Product Expansion in Japan, Arikayce Frontline Filing Set for 2026 with More to Follow
  February 28, 2024

• BUSINESS Japan Drug Market Tops 11 Trillion Yen for 1st Time Driven by Oncologics: IQVIA
  February 27, 2024

• BUSINESS As Wegovy Hits Japan Market, Novo Re-Stresses Need for Proper Use
  February 26, 2024

• REGULATORY Drug Comparisons in Promotional Activities Allowed under 4 Conditions: MHLW
  February 26, 2024

• REGULATORY Japan to Revisit Vaccine Lot Release Process to Eradicate Double Testing
  February 22, 2024

• REGULATORY New Doctor Payment Disclosure Rule to Apply to Foreign Firms with Japan Subsidiaries
  February 21, 2024

• REGULATORY Japan to End Public Aid for COVID Drugs at March-End
  February 21, 2024

• REGULATORY Xocova, Astellas’s Gastric Cancer Med Up for PAFSC Review on March 4; Pfizer’s Bispecific, RSV Jab Also on Agenda
  February 20, 2024

• BUSINESS Gilead Japan Ramping Up Sales Force with Trodelvy Now under Review
  February 20, 2024

• BUSINESS Active Pharma Hid Botched API Production, Source Reveals Details of Violations
  February 19, 2024

• BUSINESS Cancer Specialist BeiGene Set to Enter Japan Market as Early as This Year
  February 16, 2024

• BUSINESS GSK Japan Nets 11% Sales Rise in 2023, Sees 6% CAGR through 2026: President
  February 15, 2024

• REGULATORY Japan to Announce New Drug Prices on March 5
  February 15, 2024

• REGULATORY Chuikyo Issues 2024 Reform Recommendation; 1,000 Yen Premium Set for Inpatient Biosimilar Use
  February 14, 2024

• REGULATORY Japan Approves Jardiance for CKD, Label Expansion for Opdivo and More
  February 13, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• …
• Next ›
• 最終 »